The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
Abstract
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention (CDC) and National Cancer Institute (NCI), is the largest population-based cancer registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous reports in terms of completeness and accuracy and is the first CBTRUS Report to provide the distribution of molecular markers for selected brain and CNS tumor histologies. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 24.25 (Malignant AAAIR=7.06, Non-malignant AAAIR=17.18). This overall rate was higher in females compared to males (26.95 versus 21.35) and non-Hispanics compared to Hispanics (24.68 versus 22.12). The most commonly occurring malignant brain and other CNS tumor was glioblastoma (14.3% of all tumors and 49.1% of malignant tumors), and the most common non-malignant tumor was meningioma (39.0% of all tumors and 54.5% of non-malignant tumors). Glioblastoma was more common in males, and meningioma was more common in females. In children and adolescents (age 0–19 years), the incidence rate of all primary brain and other CNS tumors was 6.21. An estimated 88,190 new cases of malignant and non-malignant brain and other CNS tumors are expected to be diagnosed in the US population in 2021 (25,690 malignant and 62,500 non-malignant). There were 83,029 deaths attributed to malignant brain and other CNS tumors between 2014 and 2018. This represents an average annual mortality rate of 4.43 per 100,000 and an average of 16,606 deaths per year. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.6%, for a non-malignant brain and other CNS tumors the five-year relative survival rate was 91.8%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Self-citationUniversal sample preparation method for proteome analysis
Wiśniewski, J. R., Zougman, A., Nagaraj, N., & Mann, M. (2009) · Nature Methods · doi:10.1038/nmeth.1322 · Cited by 8,352
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Simple Features for R: Standardized Support for Spatial Vector Data
Pebesma, E. (2018) · The R Journal · doi:10.32614/rj-2018-009 · Cited by 4,701
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,442
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,189
Self-citationGlioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Self-citationStatistical Methods in Medical Research
Lachenbruch, P. A. (1972) · Technometrics · doi:10.1080/00401706.1972.10488903 · Cited by 1,703
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., Silver, J. S., Stark, P. C., Macdonald, D. R., Ino, Y., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.19.1473 · Cited by 1,610
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
International Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
van den Bent, M. J., Brandes, A. A., Taphoorn, M. J. B., Kros, J. M., Kouwenhoven, M. C. M., Delattre, J.-Y., Bernsen, H. J. J. A., Frenay, M., Tijssen, C. C., Grisold, W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2229 · Cited by 1,226
Mackay, A., Burford, A., Carvalho, D., Izquierdo, E., Fazal-Salom, J., Taylor, K. R., Bjerke, L., Clarke, M., Vinci, M., Nandhabalan, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.017 · Cited by 1,212
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Cairncross, G., Wang, M., Shaw, E., Jenkins, R., Brachman, D., Buckner, J., Fink, K., Souhami, L., Laperriere, N., Curran, W., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2674 · Cited by 1,156
The whole-genome landscape of medulloblastoma subtypes
Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Kool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Journal of the National Cancer Institute
(1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1387 · Cited by 832
Hegi, M. E., Liu, L., Herman, J. G., Stupp, R., Wick, W., Weller, M., Mehta, M. P., & Gilbert, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5964 · Cited by 812
Medulloblastomics: the end of the beginning
Northcott, P. A., Jones, D. T. W., Kool, M., Robinson, G. W., Gilbertson, R. J., Cho, Y.-J., Pomeroy, S. L., Korshunov, A., Lichter, P., Taylor, M. D., et al. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3410 · Cited by 663
Advances in the molecular genetics of gliomas — implications for classification and therapy
Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B., & Weller, M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.204 · Cited by 662
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Ostrom, Q. T., Cote, D. J., Ascha, M., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1789 · Cited by 614
Self-citationAge standardization of death rates: implementation of the year 2000 standard.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 612
van den Bent, M. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0725-7 · Cited by 577
Efficient interval estimation for age-adjusted cancer rates
Tiwari, R. C., Clegg, L. X., & Zou, Z. (2006) · Statistical Methods in Medical Research · doi:10.1177/0962280206070621 · Cited by 566
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
Stupp, R., Hegi, M. E., Gilbert, M. R., & Chakravarti, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8554 · Cited by 529
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Jones, C., & Baker, S. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3811 · Cited by 298
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Estimating Average Annual Percent Change for Disease Rates without Assuming Constant Change
Fay, M. P., Tiwari, R. C., Feuer, E. J., & Zou, Z. (2006) · Biometrics · doi:10.1111/j.1541-0420.2006.00528.x · Cited by 237
Hoffman, L. M., DeWire, M., Ryall, S., Buczkowicz, P., Leach, J., Miles, L., Ramani, A., Brudno, M., Kumar, S. S., Drissi, R., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0269-0 · Cited by 199
Females have the survival advantage in glioblastoma
Ostrom, Q. T., Rubin, J. B., Lathia, J. D., Berens, M. E., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy002 · Cited by 192
Self-citationWöhrer, A., Waldhör, T., Heinzl, H., Hackl, M., Feichtinger, J., Gruber-Mösenbacher, U., Kiefer, A., Maier, H., Motz, R., Reiner-Concin, A., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9938-9 · Cited by 189
Molecular subgroups of medulloblastoma
Northcott, P. A., Dubuc, A. M., Pfister, S., & Taylor, M. D. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.66 · Cited by 187
Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System
Zullig, L. L., Jackson, G. L., Dorn, R. A., Provenzale, D. T., McNeil, R., Thomas, C. M., & Kelley, M. J. (2012) · Military Medicine · doi:10.7205/milmed-d-11-00434 · Cited by 183
QI, S., YU, L., LI, H., OU, Y., QIU, X., DING, Y., HAN, H., & ZHANG, X. (2014) · Oncology Letters · doi:10.3892/ol.2014.2013 · Cited by 169
Aldape, K., Simmons, M. L., Davis, R. L., Miike, R., Wiencke, J., Barger, G., Lee, M., Chen, P., & Wrensch, M. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2342::aid-cncr19>3.0.co;2-x · Cited by 164
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
Grill, J., Puget, S., Andreiuolo, F. D. M., Philippe, C., MacConaill, L. E., & Kieran, M. W. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24060 · Cited by 130
van den Bent, M. J., Erdem‐Eraslan, L., Idbaïh, A., de Rooi, J., Eilers, P. H. C., Spliet, W. G. M., den Dunnen, W. F. A., Tijssen, C. C., Wesseling, P., Smitt, P. A. E. S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1157 · Cited by 127
Genomic Insights into Diffuse Intrinsic Pontine Glioma
Lapin, D. H., Tsoli, M., & Ziegler, D. S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00057 · Cited by 90
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma
Gittleman, H. R., Ostrom, Q. T., Stetson, L. C., Waite, K. A., Hodges, T. R., Wright, C. H., Wright, J. M., III, Rubin, J. B., Berens, M. E., Lathia, J. D., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz019 · Cited by 85
Self-citationWeir, H. K., Johnson, C. J., Mariotto, A. B., Turner, D., Wilson, R. J., Nishri, D., & Ward, K. C. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu018 · Cited by 82
Kruchko, C., Ostrom, Q. T., Gittleman, H. R., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy006 · Cited by 68
Self-citationBrain tumors in Sweden: Data from a population-based registry 1999–2012
Asklund, T., Malmström, A., Bergqvist, M., Björ, O., & Henriksson, R. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.975369 · Cited by 67
Modeling Reporting Delays and Reporting Corrections in Cancer Registry Data
Midthune, D. N., Fay, M. P., Clegg, L. X., & Feuer, E. J. (2005) · Journal of the American Statistical Association · doi:10.1198/016214504000001899 · Cited by 65
Computation of Graphlet Orbits for Nodes and Edges in Sparse Graphs
Hočevar, T., & Demčar, J. (2016) · Journal of Statistical Software · doi:10.18637/jss.v071.i10 · Cited by 63
Consensus Conference on Brain Tumor Definition for Registration
McCarthy, B. J., Surawicz, T. S., Bruner, J. M., et al. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.2.134 · Cited by 62
Predicting US‐ and state‐level cancer counts for the current calendar year
Zhu, L., Pickle, L. W., Ghosh, K., Naishadham, D., Portier, K. M., Chen, H., Kim, H., Zou, Z., Cucinelli, J. E., Kohler, B., et al. (2012) · Cancer · doi:10.1002/cncr.27405 · Cited by 58
Walker, E., Davis, F. G., affiliates, C. F., Shaw, A. K., Louchini, R., Shack, L., Woods, R. R., Kruchko, C. A., Spinelli, J., Guiot, M., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy195 · Cited by 49
Self-citationReport of the Second Workshop on Age Adjustment.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 41
Ostrom, Q. T., Gittleman, H. R., Kruchko, C., Louis, D. N., Brat, D. J., Gilbert, M. R., Petkov, V. I., & Barnholtz‐Sloan, J. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2217-7 · Cited by 39
Self-citationFrontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors
Paldor, I., Pearce, F. C., Drummond, K. J., & Kaye, A. H. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.05.017 · Cited by 38
Vogelbaum, M. A., Hu, C., Peereboom, D. M., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1845-7 · Cited by 35
Lym, R. L., Ostrom, Q. T., Kruchko, C., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1775-4 · Cited by 26
Self-citationPilocytic astrocytoma: Where do they belong in cancer reporting?
Ostrom, Q. T., Kruchko, C., & Barnholtz‐Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz202 · Cited by 23
Self-citationAre Benign and Borderline Brain Tumors Underreported?
Li, X., Kruchko, C., Wu, X., Hsieh, M., Andrews, P. A., Huang, B., Qiao, B., & Wohler, B. (2016) · PubMed · Cited by 22
Self-citationKruchko, C., Gittleman, H. R., Ruhl, J., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz029 · Cited by 21
Self-citationWilson, R. J., O’Neil, M. E., Ntekop, E., et al. (2014) · PubMed · Cited by 20
Data comparability and quality.
Bray, F., Kohler, B., & Ferlay, J. (2014) · PubMed · Cited by 13
Cited by
Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644
Management of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Brain and other central nervous system tumor statistics, 2021
Miller, K. D., Ostrom, Q. T., Kruchko, C., Patil, N., Tihan, T., Cioffi, G., Fuchs, H. E., Waite, K. A., Jemal, A., Siegel, R. L., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21693 · Cited by 997
Self-citationPrimary brain tumours in adults
van den Bent, M. J., Geurts, M., French, P. J., Smits, M., Capper, D., Bromberg, J. E. C., & Chang, S. M. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01054-1 · Cited by 419
Metadata
- Authors
- Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-01
- Volume
- 23
- Issue
- Supplement_3
- Pages
- iii1-iii105
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W4200327950
- Cited by
- 2,529
- References
- 69
- FWCI
- 197.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.